- Home
- STRR vs EVOK Comparison
STRR vs EVOK Comparison
Compare STRR & EVOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRR
- EVOK
- Stock Information
- Founded
- STRR 1985
- EVOK 2007
- Country
- STRR United States
- EVOK United States
- Employees
- STRR N/A
- EVOK N/A
- Industry
- STRR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- EVOK Biotechnology: Pharmaceutical Preparations
- Sector
- STRR Health Care
- EVOK Health Care
- Exchange
- STRR Nasdaq
- EVOK Nasdaq
- Market Cap
- STRR 7.0M
- EVOK 7.0M
- IPO Year
- STRR N/A
- EVOK 2013
- Fundamental
- Price
- STRR $2.28
- EVOK $4.64
- Analyst Decision
- STRR
- EVOK
- Analyst Count
- STRR 0
- EVOK 0
- Target Price
- STRR N/A
- EVOK N/A
- AVG Volume (30 Days)
- STRR 22.9K
- EVOK 36.6K
- Earning Date
- STRR 11-19-2024
- EVOK 11-07-2024
- Dividend Yield
- STRR N/A
- EVOK N/A
- EPS Growth
- STRR N/A
- EVOK N/A
- EPS
- STRR N/A
- EVOK N/A
- Revenue
- STRR $50,375,000.00
- EVOK $8,617,036.00
- Revenue This Year
- STRR $15.58
- EVOK $97.35
- Revenue Next Year
- STRR $36.27
- EVOK $99.52
- P/E Ratio
- STRR N/A
- EVOK N/A
- Revenue Growth
- STRR 2.22
- EVOK 100.35
- 52 Week Low
- STRR $2.06
- EVOK $3.54
- 52 Week High
- STRR $5.35
- EVOK $12.84
- Technical
- Relative Strength Index (RSI)
- STRR 39.15
- EVOK 49.17
- Support Level
- STRR $2.13
- EVOK $4.40
- Resistance Level
- STRR $2.43
- EVOK $5.10
- Average True Range (ATR)
- STRR 0.16
- EVOK 0.39
- MACD
- STRR 0.03
- EVOK -0.00
- Stochastic Oscillator
- STRR 34.37
- EVOK 28.39
About STRR Star Equity Holdings Inc.
Star Equity Holdings Inc is a multi-industry diversified holding company with two segments: The construction segment manufactures modular housing units for commercial and residential applications. It operates in two businesses: modular building manufacturing and structural wall panel and wood foundation manufacturing, including building supply retail operations, and The investments segment holds corporate-owned real estate, which currently includes two manufacturing facilities in Maine that it leases back to KBS and manufacturing facility. The company derives maximum revenue from Construction Segment.
About EVOK Evoke Pharma Inc.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.